Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weed killer glyphosate, the German chemicals company's CEO said in a draft speech released on Thursday.

Bayer defends safety of the herbicide, but legal costs may force withdrawal from U.S. market